益生菌联合有氧运动对肥胖型2型糖尿病合并代谢综合征患者代谢及心肺功能的影响OA
Effects of probiotics combined with aerobic exercise on metabolism and cardiopulmonary function in obese type 2 dia-betes patients
目的 探讨有氧运动干预联合益生菌对肥胖型2型糖尿病合并代谢综合征(T2DM-MS)患者代谢及心肺功能的影响.方法 选取2022年8月—2024年8月山西医科大学第一医院全科收治的肥胖型T2DM-MS患者160例为研究对象,根据随机数字表法分为研究组(有氧运动干预联合益生菌)和对照组(益生菌),每组各80例,均进行相应干预12周.比较2组治疗前后相关临床资料、血糖指标、代谢指标、肺功能、心功能变化情况.结果 治疗12 周后,研究组腰围、BMI、收缩压、舒张压均低于对照组(t/P=2.260/0.025、2.613/0.010、2.279/0.024、2.195/0.030);研究组空腹血糖(FPG)、餐后2小时血糖(2hPG)、糖化血红蛋白(HbA1c)水平均低于对照组(t/P=5.128/<0.001、4.727/<0.001、3.499/0.001);研究组总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)低于对照组,高密度脂蛋白胆固醇(HDL-C)高于对照组(t/P=2.235/0.027、3.292/<0.001、4.997/<0.001、2.412/0.017);研究组肺活量(FVC)、第1秒用力呼气容积(FEV1)、最大自主通气量(MVV)均高于对照组(t/P=3.467/0.001、13.949/<0.001、20.515/<0.001);研究组左心室射血分数(LVEF)高于对照组,左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)低于对照组(t/P=4.493/<0.001、4.625/<0.001、7.516/<0.001).结论 有氧运动干预联合益生菌可显著改善肥胖型T2DM-MS患者的糖脂代谢指标和心肺功能,为该病的综合干预提供了新的思路.
Objective This study aims to explore the effects of aerobic exercise intervention combined with probiot-ics on metabolic indicators and cardiopulmonary function in obese patients with type 2 diabetes mellitus and metabolic syn-drome(T2DM-MS).Methods From August 2022 to August 2024,163 T2DM-MS patients who visited the Department of General Practice at First Hospital of Shanxi Medical University were assigned into a test group(aerobic exercise intervention combined with probiotics)and a control group(probiotics alone)using a random number table method,with 80 patients in each group.The changes in clinical parameters,blood glucose indicators,metabolic indicators,lung function,and heart function were compared between the two groups.Results After treatment,waist circumference and blood pressure decreased in both groups,with the test group showing significantly lower values than the control group(t/P=2.260/0.025,2.613/0.010,2.279/0.024,2.195/0.030).There was no significant change in BMI in the control group before and after treatment(P>0.05),while BMI in the test group decreased and was significantly lower than that in the control group(t/P=1.988/0.049).FPG,HbA1c,and 2hPG decreased in both groups after treatment,with significantly lower levels in the test group compared to the control group(t/P=5.128/<0.001,4.727/<0.001,3.499/0.001).After treatment,TC,TG,and LDL-C in the test group decreased and were significantly lower than those in the control group(t/P=2.235/0.027,3.292/<0.001,4.997/<0.001),while HDL-C lev-els increased and were significantly higher than those in the control group(t/P=2.412/0.017).After treatment,forced vital ca-pacity(FVC),forced expiratory volume in one second(FEV1),and maximum voluntary ventilation(MVV)in the test group increased and were significantly higher than those in the control group.No statistically significant differences were observed in these pulmonary function indicators in the control group before and after intervention.After treatment,left ventricular ejection fraction(LVEF)in the test group increased(and was significantly higher than that in the control group),while left ventricular end-diastolic diameter(LVEDD)and left ventricular end-systolic diameter(LVESD)decreased(and were significantly lower than those in the control group).Compared with before intervention,no statistically significant differences were observed in various cardiac function indicators in the control group.Conclusion Aerobic exercise intervention combined with probiotics can significantly improve glucose and lipid metabolism indicators and cardiopulmonary function in patients with T2DM-MS,providing new insights for comprehensive intervention of this disease.
王伟;兰丽珍;刘敏;杜瑞
030000 太原,山西医科大学第一医院全科030000 太原,山西医科大学第一医院全科030000 太原,山西医科大学第一医院全科030000 太原,山西医科大学第一医院全科
医药卫生
2型糖尿病代谢综合征肥胖有氧运动干预益生菌糖脂代谢心肺功能疗效
Type 2 diabetes mellitusMetabolic syndromeObesityAerobic exercise interventionProbioticsGlucose and lipid metabolismCardiopulmonary functionTherapeutic effect
《疑难病杂志》 2026 (3)
257-261,5
山西省卫健委科研课题计划项目(2021127) Research Project of Shanxi Provincial Health Commission(2021127)
评论